Lithium fluxes in human erythrocytes

Area of Science:

• Pharmacology
• Cellular Physiology
• Biochemistry

Background:

• Lithium (Li+) is a crucial mood-stabilizing drug for bipolar disorder.
• Understanding Li+ transport in erythrocytes is vital for therapeutic drug monitoring.
• Previous studies have not fully quantified the contribution of various transport pathways.

Purpose of the Study:

• To quantitatively determine the contribution of four transport pathways to Li+ influx and efflux in human erythrocytes.
• To compare Li+ transport parameters at concentrations relevant to clinical treatment.
• To investigate interindividual variations in Li+ transport.

Main Methods:

• Simultaneous measurement of all transport pathways on individual blood samples.
• Utilized Li+ concentrations comparable to in vivo therapeutic levels.
• Quantitative analysis of Li+ influx and efflux rates.

Main Results:

• Lithium efflux is predominantly via countertransport (75%) and a leak pathway (25%).
• Lithium influx is mainly through a leak pathway (70%), with the bicarbonate-sensitive pathway contributing 30%.
• The Na+-K+ pump shows no significant role in Li+ transport under physiological conditions.

Conclusions:

• Lithium efflux exceeds influx in human erythrocytes under physiological conditions.
• Interindividual variability in Na+-Li+ counter-transport significantly affects Li+ efflux but not influx.
• These findings provide quantitative insights into lithium pharmacokinetics in red blood cells.